Sickle Cell Disease Association of America Extends its COVID-19 Emergency Fundraiser
The Need Continues to Grow
The Sickle Cell Disease Association of America is extending its COVID-19 Emergency Fund Campaign to raise funds and deploy critical resources to nonprofits that serve sickle cell patients and their families through sicklecelldisease.org/covid-19. While we met our initial goal of $100,000 through the generosity of Global Blood Therapeutics (GBT), the need continues to increase.
“We are in uncharted waters with COVID-19, which is creating growing challenges for our sickle cell community. This is a time when our advocacy is most needed,” said Beverley Francis-Gibson, President of the Sickle Cell Disease Association of America. “We must work together to support those most impacted in our communities.”
Sickle cell disease (SCD) is an inherited blood disorder. It alters the flow of hemoglobin – the red blood cell molecule that delivers life-giving oxygen to the body’s organs and tissues – which can cause life-threatening multi-organ failure, debilitating pain, and even death.
SCDAA’s member organizations are on the frontline of support, including assisting with food security, housing, childcare and healthcare. “We are continuing to assess where assistance may be needed, accept donations, and provide the critical funding needed,” said Francis-Gibson, “which is why we have decided to extend our fundraising campaign.”
Those looking to help can donate to the COVID-19 Emergency Fund to support nonprofits that are assisting community members affected by COVID-19. Those organizations that meet the basic needs of sickle cell patients are eligible for operating support including those that provide child care, food, housing, health care, mental health and tele health services, as well as those that support our local health care system and frontline health care workers.
SCDAA’s nonprofit member organizations can continue to apply for funding at sicklecelldisease.org/covid-19. Funds will be made available on a rolling basis.
For more information, go to www.sicklecelldisease.org.